279 related articles for article (PubMed ID: 31795956)
1. Clonal relationship of synchronous head and neck cancer and esophageal cancer assessed by single nucleotide polymorphism-based loss of heterozygosity analysis.
Sunpaweravong S; Bunbanjerdsuk S; Pongrujikorn T; Naktang C; Sunpaweravong P; Nitiruangjaras A; Dechaphankul T; Jinawath N
BMC Cancer; 2019 Dec; 19(1):1174. PubMed ID: 31795956
[TBL] [Abstract][Full Text] [Related]
2. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of cells of origin of squamous cell carcinomas in head-and-neck, esophagus, and lung.
Qu N; Huang D; Xu Q; Wang J; Chen C; Ji Q; Wu W; Zhu Y; Xu M
Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):211-214. PubMed ID: 31960064
[No Abstract] [Full Text] [Related]
6. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for one-stage concurrent surgical resection and reconstruction of synchronous esophageal and head and neck squamous cell carcinoma.
Lin YH; Ou CY; Lee WT; Lee Y-; Chang T-; Yen YT
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2929-2940. PubMed ID: 31332550
[TBL] [Abstract][Full Text] [Related]
9. Esophageal squamous cell carcinoma metachronous to head and neck cancers.
Businello G; Fassan M; Degasperi S; Traverso G; Scarpa M; Angriman I; Kotsafti A; Castagliuolo I; Sbaraglia M; Bardini R; Scarpa M
Pathol Res Pract; 2021 Mar; 219():153346. PubMed ID: 33545655
[TBL] [Abstract][Full Text] [Related]
10. Screening for synchronous esophageal second primary tumors in patients with head and neck cancer.
van de Ven SEM; de Graaf W; Bugter O; Spaander MCW; Nikkessen S; de Jonge PJF; Hardillo JA; Sewnaik A; Monserez DA; Mast H; Keereweer S; Bruno MJ; Baatenburg de Jong RJ; Koch AD
Dis Esophagus; 2021 Oct; 34(10):. PubMed ID: 34075402
[TBL] [Abstract][Full Text] [Related]
11. Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships.
Califano J; Leong PL; Koch WM; Eisenberger CF; Sidransky D; Westra WH
Clin Cancer Res; 1999 Jul; 5(7):1862-7. PubMed ID: 10430093
[TBL] [Abstract][Full Text] [Related]
12. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
[TBL] [Abstract][Full Text] [Related]
14. Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms.
McGarey PO; O'Rourke AK; Owen SR; Shonka DC; Reibel JF; Levine PA; Jameson MJ
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):40-5. PubMed ID: 26633039
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array.
Hu N; Wang C; Hu Y; Yang HH; Kong LH; Lu N; Su H; Wang QH; Goldstein AM; Buetow KH; Emmert-Buck MR; Taylor PR; Lee MP
BMC Genomics; 2006 Nov; 7():299. PubMed ID: 17134496
[TBL] [Abstract][Full Text] [Related]
16. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
[TBL] [Abstract][Full Text] [Related]
17. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.
Saeki H; Kitao H; Yoshinaga K; Nakanoko T; Kubo N; Kakeji Y; Morita M; Maehara Y
Clin Cancer Res; 2011 Apr; 17(7):1731-40. PubMed ID: 21325068
[TBL] [Abstract][Full Text] [Related]
18. DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.
Chen Y; Chen C
Head Neck; 2008 Oct; 30(10):1361-83. PubMed ID: 18642290
[TBL] [Abstract][Full Text] [Related]
19. [Analyzing the profile of chromosomal imbalances in esophageal atypical hyperplasia and early stage esophageal squamous cell carcinoma by 250K Snp Array].
Zhang X; Zhu ZH; Lin P; Yang H; Fu JH; Zhang LJ; Long H; Wen J; Huang XP; Fang Y; Rong TH
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2636-41. PubMed ID: 19080713
[TBL] [Abstract][Full Text] [Related]
20. Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma.
Bunbanjerdsuk S; Vorasan N; Saethang T; Pongrujikorn T; Pangpunyakulchai D; Mongkonsiri N; Arsa L; Thokanit N; Pongsapich W; Anekpuritanang T; Ngamphaiboon N; Jinawath A; Sunpaweravong S; Pisitkun T; Suktitipat B; Jinawath N
Mod Pathol; 2019 Jul; 32(7):943-956. PubMed ID: 30737471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
